Experts discuss latest advancements in gynecological diseases at 2nd China Research Forum

NewsGuard 100/100 Score

DK Sinopharma, Inc. (OTCBB: DKSP) (the "Company" or "DKSP") successfully co-hosted the 2nd China Western Gynecological Diseases Research Forum along with China Physician Association Gynecology Branch and Shaanxi Pharmacology Academic Council. Many experts and scholars in gynecology attended the conference, including 146 gynecologists from large hospitals across China.

“We were pleased to host these conferences, which gathered experts and gynecologists from across China to discuss the research and development of the treatment of gynecological diseases”

On April 10, 2010, the Company also hosted the first China Western Gynecological Diseases Research Forum.

"We were pleased to host these conferences, which gathered experts and gynecologists from across China to discuss the research and development of the treatment of gynecological diseases," said Professor Dongke Zhao, the founder and CEO of DKSP. As Vice-Chairman of Shaanxi Pharmacology Academic Council, Professor Zhao is widely respected in the Chinese pharmaceutical industry. "In addition to promoting research and development, the Research Forum has been an important opportunity to demonstrate the leadership of DKSP in women's healthcare."

In this conference, gynecologists from different hospitals had an extensive communication and exchange regarding the clinical efficiency of Gynecologic Inflammation Relieving Capsule, one of the Company's patented and National Medical Insurance covered products. They also shared their experiences of clinical medical use. After the conference, all the experts and gynecologists visited the Company's production plant in Yangling. The visit enhanced their understanding of DKSP's entire production process, production normalization and special attention on drug's therapeutic efficiency.

With the help of the Specialized Academic Promotion, sales of Gynecologic Inflammation Relieving Capsule increased 81% by the end of September, compared to the same period in 2009.

Source:

DK Sinopharma, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies